{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)
Status:
Investigational
Source:
NCT00537381: Phase 2 Interventional Completed Prostatic Neoplasms
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01101581: Phase 1/Phase 2 Interventional Withdrawn Non Hodgkin's Lymphoma
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00989586: Phase 1/Phase 2 Interventional Completed Lymphoma
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00551213: Phase 2 Interventional Completed Colorectal Cancer
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01614795: Phase 2 Interventional Completed Childhood Alveolar Soft Part Sarcoma
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03422536: Phase 2 Interventional Completed Head and Neck Basaloid Carcinoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01205438: Phase 3 Interventional Completed Systemic Lupus Erythematosus
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00992186: Phase 2 Interventional Completed Prostate Cancer
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00738582: Phase 2 Interventional Completed Malignant Pleural Mesothelioma
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00738764: Phase 1 Interventional Completed Cancer
(2008)
Source URL:
Class:
PROTEIN